Top

Molecular Imaging and Biology

Published in:

01-11-2009 | Research Article

FDG-Accumulating Atherosclerotic Plaques Identified with ¹⁸F-FDG-PET/CT in 141 Patients

Authors: Johan A. Wassélius, Stig A. Larsson, Hans Jacobsson

Published in: Molecular Imaging and Biology | Issue 6/2009

Abstract

Purpose

The aim of this study was to describe the prevalence of atherosclerotic plaques based on [¹⁸F]-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in a large population characterized by high risk of cardiovascular disease.

Procedures

One hundred forty-one patients referred to our department for FDG-PET/CT for suspected lung cancer were re-evaluated for atherosclerotic lesions. Cardiovascular risk factors were analyzed based on patient records.

Results

Forty-two percent of the patients had three cardiovascular risk factors or more. Nine percent of all plaques were assessed as active FDG-accumulating plaques, 88% were inactive calcified plaques, and 2% were mixed. The abdominal aorta was the vessel with the highest plaque count. Patients with one risk factor had significantly less active and inactive plaques.

Conclusions

The observed association between the numbers of cardiovascular risk factors and the numbers of FDG-accumulating plaques as well as calcified plaques further supports the validity and value of FDG-PET/CT in the non-invasive identification and characterization of atherosclerotic disease.

Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868–874CrossRefPubMed

Davies MJ (1996) Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94:2013–2020PubMed

Fishbein MC, Siegel RJ (1996) How big are coronary atherosclerotic plaques that rupture? Circulation 94(10):2662–2666PubMed

Libby P (2006) Atherosclerosis: disease biology affecting the coronary vasculature. Am J Cardiol 98(12A):3Q–9QCrossRefPubMed

Bleeker-Rovers CP, Bredie SJ, van der Meer JW et al (2003) F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61(10):323–329PubMed

Blockmans D, De Ceuninck L, Vanderschueren S et al (2007) Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford) 46(4):672–677CrossRef

Lederman RJ, Raylman RR, Fisher SJ et al (2001) Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 22(7):747–753CrossRefPubMed

Ogawa M, Ishino S, Mukai T et al (2004) (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 45(7):1245–1250PubMed

Rudd JH, Warburton EA, Fryer TD et al (2002) Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105(23):2708–2711CrossRefPubMed

10.

Davies JR, Rudd JH, Fryer TD et al (2005) Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxy-glucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36(12):2642–2647CrossRefPubMed

11.

Tawakol A, Migrino RQ, Bashian GG et al (2006) In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48(9):1818–1824CrossRefPubMed

12.

Tahara N, Kai H, Ishibashi M et al (2006) Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48(9):1825–1831CrossRefPubMed

13.

Ben-Haim S, Kupzov E, Tamir A et al (2004) Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45(11):1816–1821PubMed

14.

Dunphy MP, Freiman A, Larson SM et al (2005) Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46(8):1278–1284PubMed

15.

Tahara N, Kai H, Yamagishi S et al (2007) Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 49(14):1533–1539CrossRefPubMed

Title: FDG-Accumulating Atherosclerotic Plaques Identified with 18F-FDG-PET/CT in 141 Patients
Authors: Johan A. Wassélius
Stig A. Larsson
Hans Jacobsson
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: Molecular Imaging and Biology / Issue 6/2009
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI: https://doi.org/10.1007/s11307-009-0223-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

FDG-Accumulating Atherosclerotic Plaques Identified with ¹⁸F-FDG-PET/CT in 141 Patients

Abstract

Purpose

Procedures

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Procedures

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2009

Letter to the Editor

64Cu-Labeled PEGylated Polyethylenimine for Cell Trafficking and Tumor Imaging

[11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis

Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

Death and Proliferation Time Course of Stem Cells Transplanted in the Myocardium

Letter to the Editor